Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Ann Intern Med
    April 2024
  1. YEN FS, Hwu CM, Liu JS, Wu YL, et al
    Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease.
    Ann Intern Med. 2024 Apr 30. doi: 10.7326/M23-1874.
    >> Share

  2. GREENWOOD H, Barnes K, Clark J, Ball L, et al
    Long-Term Effect of Salt Substitution for Cardiovascular Outcomes : A Systematic Review and Meta-Analysis.
    Ann Intern Med. 2024 Apr 9. doi: 10.7326/M23-2626.
    >> Share


  3. Annals Video Summary - Long-Term Effect of Salt Substitution for Cardiovascular Outcomes: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2024 Apr 9:eM240208. doi: 10.7326/M24-0208.
    >> Share

  4. KIRSCHNER J, Hunter B
    In suspected ACS, hs-cTnI- vs. c-cTnI-guided care was associated with improved outcomes at 5 y in certain subgroups.
    Ann Intern Med. 2024;177:JC41.
    >> Share

    March 2024
  5. WEISS J, Raghu VK, Paruchuri K, Zinzuwadia A, et al
    Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs : A Risk Prediction Study.
    Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-1898.
    >> Share

  6. MUKHERJEE D
    In acute MI and anemia, restrictive vs. liberal transfusion did not differ for a composite of recurrent MI or death at 30 d.
    Ann Intern Med. 2024 Mar 5. doi: 10.7326/J24-0010.
    >> Share

  7. BAVISHI C
    In adults with stable angina, PCI vs. a placebo procedure reduced angina symptoms at 12 wk.
    Ann Intern Med. 2024;177:JC28.
    >> Share

  8. YONIS H, Granger CB
    In adults aged >/=80 y with NSTE-ACS, an invasive vs. conservative strategy improved outcomes at a median 5.3 y.
    Ann Intern Med. 2024;177:JC27.
    >> Share

    February 2024
  9. WEITZ HH, Merli GJ
    Web Exclusive. Annals Consult Guys - Reversals of Care Started After a Myocardial Infarction.
    Ann Intern Med. 2024;177:eW230013.
    >> Share

    January 2024
  10. CENTOR RM, Jackevicius CA
    Annals On Call - Low-Cost Generic Cardiovascular Drugs.
    Ann Intern Med. 2024 Jan 2:eA230001. doi: 10.7326/A23-0001.
    >> Share

    December 2023
  11. SUD M, Sivaswamy A, Austin PC, Anderson TJ, et al
    Development and Validation of the CANHEART Population-Based Laboratory Prediction Models for Atherosclerotic Cardiovascular Disease.
    Ann Intern Med. 2023 Dec 12. doi: 10.7326/M23-1345.
    >> Share

  12. KIM CJ, Sussman JB, Mukamal KJ, Eades M, et al
    Trends in Primary Prevention Statin Use by Cardiovascular Risk Score From 1999 to 2018: A Repeated Cross-Sectional Study.
    Ann Intern Med. 2023 Dec 5. doi: 10.7326/M23-1915.
    >> Share

  13. GLICK M
    Annals Graphic Medicine - The Heart Attack.
    Ann Intern Med. 2023;176:eG220077.
    >> Share

  14. MORENO R
    In acute MI complicated by cardiogenic shock, ECLS did not reduce 30-d all-cause mortality.
    Ann Intern Med. 2023;176:JC135.
    >> Share

    November 2023
  15. LIU M, Aggarwal R, Zheng Z, Yeh RW, et al
    Cardiovascular Health of Middle-Aged U.S. Adults by Income Level, 1999 to March 2020 : A Serial Cross-Sectional Study.
    Ann Intern Med. 2023 Nov 21. doi: 10.7326/M23-2109.
    >> Share

    October 2023
  16. BUDOFF MJ, Nasir K, Blaha MJ
    Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort.
    Ann Intern Med. 2023;176:eL230262.
    >> Share

  17. KOFOED KF, Fuchs A, Kober LV
    Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort.
    Ann Intern Med. 2023;176:eL230263.
    >> Share

    September 2023

  18. Blood Pressure Level in Late Adolescence and Risk for Cardiovascular Events.
    Ann Intern Med. 2023 Sep 26. doi: 10.7326/P23-0007.
    >> Share

  19. RIETZ H, Pennlert J, Nordstrom P, Brunstrom M, et al
    Blood Pressure Level in Late Adolescence and Risk for Cardiovascular Events : A Cohort Study.
    Ann Intern Med. 2023 Sep 26. doi: 10.7326/M23-0112.
    >> Share

  20. TON IT, Moon J, Sengul A, Mody FV, et al
    Evidence-Based Cardiovascular Disease Medicines' Availability in Low-Cost Generic Drug Programs in the United States : A Cross-Sectional Study.
    Ann Intern Med. 2023 Sep 5. doi: 10.7326/M23-0287.
    >> Share

  21. WEITZ HH, Merli GJ
    Web Exclusive. Annals Consult Guys - Spontaneous Coronary Artery Dissection.
    Ann Intern Med. 2023;176:eW220022.
    >> Share

    August 2023
  22. WINCHESTER DE, Keating FK, Patel KK, Shah NR, et al
    The Medicare Appropriate Use Criteria Program: A Review of Recommendations for Testing in Coronary Artery Disease.
    Ann Intern Med. 2023 Aug 22. doi: 10.7326/M23-1011.
    >> Share

  23. HE J, Bundy JD, Geng S, Tian L, et al
    Social, Behavioral, and Metabolic Risk Factors and Racial Disparities in Cardiovascular Disease Mortality in U.S. Adults : An Observational Study.
    Ann Intern Med. 2023 Aug 15. doi: 10.7326/M23-0507.
    >> Share

    July 2023
  24. FRANK DA, Johnson AE, Hausmann LRM, Gellad WF, et al
    Disparities in Guideline-Recommended Statin Use for Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and Gender : A Nationally Representative Cross-Sectional Analysis of Adults in the United States.
    Ann Intern Med. 2023 Jul 25. doi: 10.7326/M23-0720.
    >> Share

  25. MCCORMICK N, Yokose C, Wei J, Lu N, et al
    Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort Study.
    Ann Intern Med. 2023 Jul 25. doi: 10.7326/M23-0724.
    >> Share


  26. Correction: Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2023 Jul 18. doi: 10.7326/L23-0249.
    >> Share

  27. KESARWANI M
    In ACS with multivessel CAD, immediate vs. staged complete revascularization was noninferior for a composite outcome at 1 y.
    Ann Intern Med. 2023;176:JC76.
    >> Share

  28. COLIVICCHI F
    In CAD, treat-to-target statins were noninferior to high-intensity statins for a composite clinical outcome.
    Ann Intern Med. 2023;176:JC74.
    >> Share

    June 2023
  29. CENTOR RM, Kofoed KF
    Annals On Call - Subclinical Coronary Atherosclerosis.
    Ann Intern Med. 2023 Jun 6:eA220011. doi: 10.7326/A22-0011.
    >> Share

  30. ZITO A, Galli M, Biondi-Zoccai G, Abbate A, et al
    Diagnostic Strategies for the Assessment of Suspected Stable Coronary Artery Disease : A Systematic Review and Meta-analysis.
    Ann Intern Med. 2023 Jun 6. doi: 10.7326/M23-0231.
    >> Share


  31. Annals Video Summary - Diagnostic Strategies for the Assessment of Suspected Stable Coronary Artery Disease.
    Ann Intern Med. 2023 Jun 6:eM231067. doi: 10.7326/M23-1067.
    >> Share

    May 2023
  32. RICHARDSON TL JR, Halvorson AE, Hackstadt AJ, Hung AM, et al
    Primary Occurrence of Cardiovascular Events After Adding Sodium-Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes.
    Ann Intern Med. 2023 May 9. doi: 10.7326/M22-2751.
    >> Share

    April 2023
  33. OSERAN AS, Wadhera RK, Orav EJ, Figueroa JF, et al
    Effect of Medicare Advantage on Hospital Readmission and Mortality Rankings.
    Ann Intern Med. 2023;176:480-488.
    >> Share

    March 2023
  34. FUCHS A, Kuhl JT, Sigvardsen PE, Afzal S, et al
    Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort : A Prospective Observational Cohort Study.
    Ann Intern Med. 2023 Mar 28. doi: 10.7326/M22-3027.
    >> Share

  35. MCDERMOTT M, Newby DE
    Contemporary Natural History of Coronary Artery Disease.
    Ann Intern Med. 2023 Mar 28. doi: 10.7326/M23-0533.
    >> Share

    January 2023
  36. WEITZ HH, Merli GJ
    Annals Consult Guys - Care of a Patient With Left Ventricular Thrombus.
    Ann Intern Med. 2023;176:eW220014.
    >> Share

    December 2022
  37. SHIN H, Schneeweiss S, Glynn RJ, Patorno E, et al
    Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin.
    Ann Intern Med. 2022;175:W155.
    >> Share

  38. QIU M
    Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin.
    Ann Intern Med. 2022;175:W155.
    >> Share

    November 2022
  39. FERGUSON E, Lang E
    In acute ischemic stroke, early IV tenecteplase was noninferior to alteplase for excellent functional outcome.
    Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0090.
    >> Share

    October 2022
  40. CAVALLI G, Leong D
    Adult survivors of a first primary invasive cancer had increased risk for cardiovascular disease.
    Ann Intern Med. 2022 Oct 4. doi: 10.7326/J22-0079.
    >> Share

    September 2022
  41. CHEW DS, Whitelaw S, Vaduganathan M, Mark DB, et al
    Patient-Reported Outcomes Measures in Cardiovascular Disease: An Evidence Map of the Psychometric Properties of Health Status Instruments.
    Ann Intern Med. 2022 Sep 20. doi: 10.7326/M22-2234.
    >> Share

    August 2022
  42. INOUE-CHOI M, Ramirez Y, Cornelis MC, Berrington de Gonzalez A, et al
    Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank : A Prospective Cohort Study.
    Ann Intern Med. 2022 Aug 30. doi: 10.7326/M22-0041.
    >> Share

  43. BOTTON J, Jabagi MJ, Bertrand M, Baricault B, et al
    Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France.
    Ann Intern Med. 2022 Aug 23. doi: 10.7326/M22-0988.
    >> Share

    July 2022
  44. KIRSCHNER JM, Hunter BR
    In intermediate-risk stable chest pain, treatment guided by initial CT vs. ICA did not differ for MACE at 3.5 y.
    Ann Intern Med. 2022 Jul 5. doi: 10.7326/J22-0047.
    >> Share

    June 2022
  45. SMETANA GW, Benson MD, Juraschek SP, Burns RB, et al
    Would You Recommend a Statin to This Patient for Primary Prevention of Cardiovascular Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2022 Jun 14. doi: 10.7326/M22-0908.
    >> Share

    May 2022
  46. SHIN H, Schneeweiss S, Glynn RJ, Patorno E, et al
    Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study.
    Ann Intern Med. 2022 May 24. doi: 10.7326/M21-4012.
    >> Share


  47. Summary for Patients: Risk for Heart Attack After Eye Procedures.
    Ann Intern Med. 2022;175:I22.
    >> Share

    April 2022
  48. HOLT A, Blanche P, Jensen AKG, Nouhravesh N, et al
    Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease : A Case-Crossover Study.
    Ann Intern Med. 2022 Apr 19. doi: 10.7326/M21-3445.
    >> Share


  49. Summary for Patients: Risk for Unwanted Outcomes in Men Prescribed Both Drugs for Erectile Dysfunction and Nitrates for Angina.
    Ann Intern Med. 2022 Apr 19. doi: 10.7326/P22-0006.
    >> Share

    March 2022
  50. SEN A, Gemes K, Stalhammar G, Svensen C, et al
    Risk for Acute Myocardial Infarction After Ophthalmologic Procedures.
    Ann Intern Med. 2022 Mar 22. doi: 10.7326/M20-6618.
    >> Share

  51. MURPHY E, McEvoy JW
    Does Stopping Aspirin Differ Fundamentally From Not Starting Aspirin in the Primary Prevention of Cardiovascular Disease Among Older Adults?
    Ann Intern Med. 2022 Mar 15. doi: 10.7326/M22-0550.
    >> Share

  52. SILVESTRI EG, Borzak S
    In patients with MI or high-risk coronary disease, influenza vaccination reduced CV events at 12 mo.
    Ann Intern Med. 2022 Mar 1. doi: 10.7326/J22-0006.
    >> Share

  53. BACH RG
    DAPT de-escalation from ticagrelor to clopidogrel 1 mo after PCI for acute MI reduced net clinical events at 1 y.
    Ann Intern Med. 2022;175:JC27.
    >> Share

    February 2022
  54. LARDARO T, Hunter BR
    In suspected or provisionally diagnosed ACS, early CTCA did not reduce mortality or nonfatal MI at 1 y.
    Ann Intern Med. 2022;175:JC20.
    >> Share

    January 2022
  55. PATORNO E, Htoo PT, Everett BM, Kim SC, et al
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2022;175:W4.
    >> Share

  56. PATORNO E, Htoo PT, Glynn RJ, Schneeweiss S, et al
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2022;175:W4-W5.
    >> Share

  57. BEPO L, Makam AN, Nguyen OK
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2022;175:W3.
    >> Share

  58. QIU M
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2022;175:W3-W4.
    >> Share

    December 2021
  59. YEAP BB, Marriott RJ, Antonio L, Raj S, et al
    Associations of Serum Testosterone and Sex Hormone-Binding Globulin With Incident Cardiovascular Events in Middle-Aged to Older Men.
    Ann Intern Med. 2021 Dec 28. doi: 10.7326/M21-0551.
    >> Share

  60. ZHAO D, Guallar E
    Testosterone and Cardiovascular Disease in Men.
    Ann Intern Med. 2021 Dec 28. doi: 10.7326/M21-4777.
    >> Share

  61. KANNER L, Glatt AE
    Patients with COVID-19 had increased risk for acute MI and ischemic stroke at 14 d vs. matched controls.
    Ann Intern Med. 2021 Dec 7. doi: 10.7326/ACPJ202112210.
    >> Share

  62. CENTOR RM, Patorno E
    Annals On Call - SGLT2 Versus GLP1 for Cardiovascular Prevention.
    Ann Intern Med. 2021;174:OC1.
    >> Share

  63. MURRAY H, Petrie C
    In suspected ACS, an unmasked 0/1-h vs. masked 0/3-h hs-cTnT protocol did not differ for death or MI at 1 y.
    Ann Intern Med. 2021;174:JC139.
    >> Share

  64. FAWZY AM, Lip GYH
    In ACS, de-escalation of DAPT reduces bleeding and does not increase ischemic events vs. other DAPT strategies.
    Ann Intern Med. 2021;174:JC138.
    >> Share

    November 2021
  65. CHIANG CH, Chiang CH, Pickering JW, Stoyanov KM, et al
    Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis.
    Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-1499.
    >> Share

    October 2021
  66. BURNS RB, Pignone M, Michos ED, Kanjee Z, et al
    Would You Recommend Aspirin to This Patient for Primary Prevention of Atherosclerotic Cardiovascular Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2021 Oct 12. doi: 10.7326/M21-2596.
    >> Share

    September 2021
  67. PATORNO E, Htoo PT, Glynn RJ, Schneeweiss S, et al
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2021 Sep 28. doi: 10.7326/M21-0893.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016